The hexosamine biosynthesis pathway in metabolism and cell fate
- Institution
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ
- Principal investigator
- Estela Jacinto
- Funding
- $334K
- Duration
- 2020–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Cell fate is determined by a number of factors including genetics, cellular signals and availability of nutrients. How cells process these numerous inputs to produce a specific output, such as cell differentiation or proliferation remains poorly understood. Our project will address how cells process these inputs following the principle of “supply and demand.” During early T cell development, the synthesis of a diverse repertoire of T cell receptors defines a robust immune system that will allow recognition of various pathogens, while tolerant to self-peptides. The synthesis of a diverse repertoire requires abundant nucleotides and hexosamines for proper synthesis and folding. Our studies will elucidate how the de novo hexosamine biosynthesis pathway reprogram metabolism via regulation of mTOR signaling and pyrimidine metabolism to generate a diverse TCR repertoire. As we gain better understanding of how these pathways are reprogrammed to balance nutrient supply with cellular demand, we hope to develop better strategies for dietary manipulation that can potentially enhance the functions of the immune system.
LOADING MOONBASE SCORE
Questions for RUTGERS BIOMEDICAL AND HEALTH SCIENCES
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Rutgers Biomedical and Health Sciences72
Single-Nuclei Multiomic Analysis of DLB Progression
Yoon-Seong Kim · $1.2M · 2022–2027
- NIH · Rutgers Biomedical and Health Sciences52
The Role of TRIM6 and Ubiquitin in Influenza Virus-Induced Pathology
Ricardo Rajsbaum · $454K · 2021–2027
- NIH · Rutgers Biomedical and Health Sciences48
Investigating the Role of SLC45A4 in GABA Metabolism
Xiaoyang Su · $322K · 2023–2028